Valuation: IXICO plc

Market Cap 16.42M 21.74M 19.08M 18.02M 30.74M 2.08B 30.96M 216M 83.53M 1.06B 81.64M 79.88M 3.42B P/E 2026 *
-5.36x
P/E 2027 * -5.77x
Enterprise Value 6.22M 8.24M 7.23M 6.83M 11.65M 790M 11.73M 81.72M 31.65M 403M 30.94M 30.27M 1.3B EV / Sales 2026 *
0.78x
EV / Sales 2027 * 1.15x
Free-Float
89.22%
Yield 2026 *
-
Yield 2027 * -
1 day-3.27%
1 week-3.27%
Current month-6.39%
1 month-6.39%
3 months-14.14%
6 months-7.87%
Current year-38.26%
1 week 7
Extreme 7
8
1 month 7
Extreme 7
8
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
19.5
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 50 2019-08-20
Director/Board Member 60 2022-01-20
Date Insider Type Main position Quantity % Market Cap. Importance
7/15/26 Buy

Chairman

50,006 0.0228%
6/13/25 Free 350,000 0.3777%
6/13/25 Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
-3.27%-3.27%-47.24%-62.60% 21.74M
+2.39%+6.23%+12.16%+38.12% 47.97B
-0.03%+0.30%+49.78%+36.91% 44.5B
-0.88%+5.79%+342.65%+622.13% 43.93B
+0.81%-0.37%+9.46%+97.82% 41.03B
+0.51%-0.61%+5.18%+46.87% 29.85B
-0.65%-1.30%+23.03%+150.08% 17.27B
-0.60%+9.32%+8.57% - 15.34B
+1.76%+0.85%+29.47%+48.42% 15.3B
+1.47%-3.70% - - 14.82B
Average +0.18%+2.22%+48.12%+122.22% 27B
Weighted average by Cap. +0.59%+2.97%+75.91%+164.86%

Financials

2026 *2027 *
Net sales 8M 10.59M 9.29M 8.78M 14.98M 1.02B 15.08M 105M 40.69M 519M 39.77M 38.91M 1.67B 9M 11.92M 10.46M 9.88M 16.85M 1.14B 16.97M 118M 45.77M 583M 44.74M 43.77M 1.88B
Net income -2.14M -2.84M -2.49M -2.35M -4.01M -272M -4.04M -28.14M -10.9M -139M -10.65M -10.42M -447M -2.8M -3.71M -3.25M -3.07M -5.24M -355M -5.28M -36.78M -14.25M -182M -13.92M -13.62M -584M
Net Debt -10.2M -13.51M -11.85M -11.19M -19.09M -1.29B -19.23M -134M -51.88M -661M -50.71M -49.61M -2.13B -6.1M -8.08M -7.09M -6.69M -11.42M -774M -11.5M -80.1M -31.02M -395M -30.32M -29.67M -1.27B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-09-28 GBX 7.500 0.00% 14,537
26-09-25 GBX 7.500 0.00% 12,529
26-09-24 GBX 7.500 +1.35% 106,916
26-09-23 GBX 7.400 -1.33% 235,066
26-09-22 GBX 7.500 0.00% 95,108
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0750GBP
Average target price
0.2600GBP
Spread / Average Target
+246.67%

Annual profits - Rate of surprise